학술논문

The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study
Document Type
Article
Source
In: Ophthalmic Surgery Lasers and Imaging Retina. (Ophthalmic Surgery Lasers and Imaging Retina, October 2022, 53(10):553-560)
Subject
Language
English
ISSN
23258179
23258160